These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 334381)

  • 1. Effector cells which mediate antibody-dependent cell-mediated cytotoxicity. II. Ontogeny of effector activity in murine spleen.
    Pollack SB; Kraft DS
    Cell Immunol; 1977 Nov; 34(1):1-9. PubMed ID: 334381
    [No Abstract]   [Full Text] [Related]  

  • 2. Effector cells for antibody-dependent cell mediated cytotoxicity. I. Increased cytotoxicity after priming with BCG-SS.
    Pollack SB
    Cell Immunol; 1977 Mar; 29(2):373-81. PubMed ID: 324637
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 5. A new method for quantitation of cell-mediated immunity in the mouse.
    Clark JM; Menduke H; Wheelock EF
    J Reticuloendothel Soc; 1979 Mar; 25(3):255-67. PubMed ID: 374732
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms by which tumors avoid destruction by the immune system BCG-catalyzed increase in IgG and IgA blocking activity of lymphocyte-mediated cytotoxicity.
    Hakim AA
    Klin Wochenschr; 1975 Sep; 53(18):881-3. PubMed ID: 1100900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice.
    Petricevich VL; Ueda C; Alves RC; da Silva MA; Moreno C; Melo AR; Dias da Silva W
    Braz J Med Biol Res; 2001 Jan; 34(1):81-92. PubMed ID: 11151032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.
    Hogarth PJ; Logan KE; Vordermeier HM; Singh M; Hewinson RG; Chambers MA
    Vaccine; 2005 Apr; 23(20):2557-64. PubMed ID: 15780437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative kinetics of spleen cell-mediated antibody-dependent cytotoxic activity in mice treated with BCG or Mycobacterium smegmatis].
    Hérodin F; Dormont D
    Ann Immunol (Paris); 1983; 134C(2):207-13. PubMed ID: 6870194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.
    Paige CJ; Figarella EF; Cuttito MJ; Cahan A; Stutman O
    J Immunol; 1978 Nov; 121(5):1827-35. PubMed ID: 361891
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of spleen natural killing activity induced by BCG.
    Ito M; Ralph P; Moore MA
    Clin Immunol Immunopathol; 1980 May; 16(1):30-8. PubMed ID: 6991179
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine immune responses to oral BCG immunization in the presence or absence of prior BCG sensitization.
    Cross ML; Lambeth MR; Aldwell FE
    Immunol Cell Biol; 2010 Feb; 88(2):224-7. PubMed ID: 19918257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the antibody response in vitro by BCG.
    Brown CA; Brown IN; Sljivíc VS
    Dev Biol Stand; 1977 Apr 13-15; 38():153-8. PubMed ID: 344094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of mitogens on ADCC activity and Fc receptor bearing cells.
    Hügin A; Matter A
    Experientia; 1983 Jan; 39(1):34-9. PubMed ID: 6337863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.
    Kiger N; Bruley-Rosset M; Huchet R; Mathe G
    Immunology; 1980 Nov; 41(3):687-94. PubMed ID: 6970164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
    Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
    Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
    Teruya K; Kawakami K; Tohyama M; Saito A
    Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher ADCC of murine peritoneal cells after immunization with allogenic tumor cells as compared with stimulation by adriamycin, BCG, and thioglycolate.
    Haisma HJ; Ligtenberg M; Dullens HF; Den Otter W
    Cell Immunol; 1986 Sep; 101(2):454-62. PubMed ID: 3530505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.